Fidelity Investments’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$111M Buy
5,439,118
+59,027
+1% +$1.2M 0.01% 1075
2025
Q1
$97.6M Buy
5,380,091
+522,423
+11% +$9.48M 0.01% 1109
2024
Q4
$123M Sell
4,857,668
-1,166,748
-19% -$29.5M 0.01% 1034
2024
Q3
$205M Sell
6,024,416
-1,804,748
-23% -$61.3M 0.01% 818
2024
Q2
$290M Sell
7,829,164
-1,896,877
-20% -$70.2M 0.02% 647
2024
Q1
$408M Buy
9,726,041
+2,675,632
+38% +$112M 0.03% 518
2023
Q4
$280M Sell
7,050,409
-38,711
-0.5% -$1.54M 0.02% 620
2023
Q3
$195M Buy
7,089,120
+1,250
+0% +$34.4K 0.02% 711
2023
Q2
$240M Buy
7,087,870
+6,792
+0.1% +$230K 0.02% 654
2023
Q1
$255M Buy
7,081,078
+16,104
+0.2% +$579K 0.02% 616
2022
Q4
$315M Buy
7,064,974
+49,131
+0.7% +$2.19M 0.03% 541
2022
Q3
$197M Buy
7,015,843
+2,699
+0% +$75.9K 0.02% 664
2022
Q2
$189M Buy
7,013,144
+2,891
+0% +$77.9K 0.02% 708
2022
Q1
$239M Buy
7,010,253
+10,673
+0.2% +$364K 0.02% 693
2021
Q4
$270M Buy
6,999,580
+1,384,247
+25% +$53.5M 0.02% 677
2021
Q3
$303M Buy
5,615,333
+5,249,038
+1,433% +$283M 0.02% 632
2021
Q2
$12.2M Buy
366,295
+28,395
+8% +$949K ﹤0.01% 2029
2021
Q1
$6.96M Buy
337,900
+337,899
+33,789,900% +$6.96M ﹤0.01% 2160
2020
Q4
$0 Sell
1
-72
-99% ﹤0.01% 3860
2020
Q3
$1K Buy
+73
New +$1K ﹤0.01% 3536
2020
Q1
Sell
-50
Closed 3673
2019
Q4
$0 Buy
50
+30
+150% ﹤0.01% 3821
2019
Q3
$0 Buy
+20
New ﹤0.01% 3811
2019
Q1
Sell
-280
Closed -$1K 3657
2018
Q4
$1K Hold
280
﹤0.01% 3379
2018
Q3
$2K Buy
+280
New +$2K ﹤0.01% 3378
2018
Q2
Sell
-397,901
Closed -$13.9M 2647
2018
Q1
$13.9M Sell
397,901
-110,282
-22% -$3.85M ﹤0.01% 1850
2017
Q4
$21.6M Sell
508,183
-88,140
-15% -$3.75M ﹤0.01% 1687
2017
Q3
$25.6M Sell
596,323
-53,974
-8% -$2.32M ﹤0.01% 1603
2017
Q2
$24.1M Sell
650,297
-289,944
-31% -$10.7M ﹤0.01% 1600
2017
Q1
$50.9M Sell
940,241
-348,233
-27% -$18.9M 0.01% 1286
2016
Q4
$68.4M Buy
1,288,474
+370,373
+40% +$19.7M 0.01% 1165
2016
Q3
$55.6M Sell
918,101
-7,060
-0.8% -$428K 0.01% 1251
2016
Q2
$60.9M Sell
925,161
-52,560
-5% -$3.46M 0.01% 1185
2016
Q1
$55.4M Sell
977,721
-8,736
-0.9% -$495K 0.01% 1208
2015
Q4
$232M Buy
986,457
+21,283
+2% +$5.01M 0.03% 598
2015
Q3
$153M Sell
965,174
-19,634
-2% -$3.1M 0.02% 770
2015
Q2
$373M Buy
984,808
+16,380
+2% +$6.2M 0.05% 426
2015
Q1
$405M Buy
968,428
+72,537
+8% +$30.3M 0.05% 411
2014
Q4
$245M Buy
895,891
+91,853
+11% +$25.1M 0.03% 589
2014
Q3
$156M Buy
804,038
+413
+0.1% +$80.3K 0.02% 760
2014
Q2
$197M Buy
803,625
+7,925
+1% +$1.94M 0.03% 678
2014
Q1
$211M Sell
795,700
-14,788
-2% -$3.92M 0.03% 630
2013
Q4
$294M Buy
810,488
+14,492
+2% +$5.26M 0.04% 461
2013
Q3
$423M Buy
795,996
+484,781
+156% +$258M 0.06% 348
2013
Q2
$72.9M Buy
+311,215
New +$72.9M 0.01% 1063